[1]
X. Zhu, R. Zhao, K. Liu, Q. Guo, C. Xu, and X. Yi, “The Clinical Utility of DWI-ADC Value in Predicting the Efficacy of TACE for Hepatocellular Carcinoma”, C. R. Acad. Bulg. Sci., vol. 79, no. 5, pp. 633–639, May 2026.